Canada markets closed

EYPT Oct 2024 35.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.07000.0000 (0.00%)
At close: 10:51AM EDT
Full screen
Previous Close0.0700
Open0.0700
Bid0.0000
Ask0.7500
Strike35.00
Expire Date2024-10-18
Day's Range0.0700 - 0.0700
Contract RangeN/A
Volume1
Open Interest14
  • GlobeNewswire

    EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    WATERTOWN, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an

  • GlobeNewswire

    EyePoint Pharmaceuticals Appoints Esteemed Industry Leader Fred Hassan to Board of Directors

    - Appointment strengthens leadership team as Company approaches dosing of patients in Phase 3 pivotal trials of DURAVYU™ in wet AMD in 2024 -WATERTOWN, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced the appointment of Fred Hassan, a distinguished industry leader to its Board of Directors. “I am hono

  • GlobeNewswire

    EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences

    WATERTOWN, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences: Morgan Stanley Annual Global Healthcare ConferenceForum: 1x1 Investor MeetingsDate: Wednesday, September 4, 2024 Baird Global Healthcare ConferenceForum: Fireside